Optimizing Outcomes in ST-Segment Elevation Myocardial Infarction: Is Prolonged Infusion of Bivalirudin Part of the Solution?

J Am Coll Cardiol. 2024 Oct 15;84(16):1525-1527. doi: 10.1016/j.jacc.2024.08.049.
No abstract available

Keywords: PCI; ST-segment elevation myocardial infarction; bleeding; stent thrombosis.

Publication types

  • Editorial
  • Letter

MeSH terms

  • Antithrombins* / administration & dosage
  • Antithrombins* / therapeutic use
  • Hirudins* / administration & dosage
  • Humans
  • Infusions, Intravenous
  • Peptide Fragments* / administration & dosage
  • Peptide Fragments* / therapeutic use
  • Recombinant Proteins* / administration & dosage
  • Recombinant Proteins* / therapeutic use
  • ST Elevation Myocardial Infarction* / drug therapy
  • ST Elevation Myocardial Infarction* / therapy
  • Treatment Outcome

Substances

  • bivalirudin
  • Hirudins
  • Peptide Fragments
  • Recombinant Proteins
  • Antithrombins